Published 15:27 IST, September 21st 2021
Bharat Biotech completes phase 2/3 trials of Covaxin for children under 18yrs
All data pertaining to the use of Covaxin for children under 18 years of age will be submitted to the DGCI by next week, as per the company.
Image: PTI | Image:
self
Advertisement
15:26 IST, September 21st 2021